{"product_id":"immunogematologicheskij-i-biohimicheskij-profil-pacientow-von-oumu-daxe-konate","title":"Immunogematologicheskij i biohimicheskij profil' pacientow","description":"\u003cp\u003eNashe issledowanie immunogematologicheskogo i biohimicheskogo profilq pacientow s VICh\/SPIDom w Uniwersitetskoj klinike Point G bylo opisatel'nym issledowaniem s prospektiwnym sborom dannyh, ohwatywaüschim period s dekabrq 2019 goda po noqbr' 2020 goda, osnownoj cel'ü kotorogo bylo izuchenie gematologicheskih i biohimicheskih immunologicheskih parametrow pacientow s VICh\/SPIDom. Iz 230 pacientow 69,1% nahodilis' na antiretrowirusnoj terapii, a 30,9% byli naiwnymi. Srednij wozrast pacientow sostawil 42,20±13,47 let, krajnie znacheniq kolebalis' ot 8 do 80 let. Zhenschin bylo bol'she wsego - 62,2%. Bol'shinstwo nashih pacientow byli inficirowany VICh-1 (94,3%). Serorasprostranennost' HBsAg sostawila 12,2%. Pacienty s CD4¿ 350\/mm3 byli predstawleny naibolee shiroko - 59,1% sluchaew. Na dolü anemii (urowen' HB ¿11 g\/dl) prishlos' 43,5% sluchaew. Nejtropeniq i trombocitopeniq sostawili 29,1% i 17,8% sootwetstwenno. Dislipidemiq nablüdalas' u 19,5% pacientow, prinimaüschih ARV-preparaty, i u 12,7% pacientow, ne prinimaüschih ARV-preparaty. Index aterogennosti byl wysokim u 65,2% pacientow.\u003c\/p\u003e\u003cdiv class=\"aw-variant-hidden-subtitle-div\" id=\"aw-variant-subtitle-9786204636498\"\u003e\u003ch3\u003einficirowannyh VICh\/SPIDom w Uniwersitetskoj bol'nice Pojnt Dzhi\u003c\/h3\u003e\u003c\/div\u003e","brand":"Autorenwelt Shop","offers":[{"title":"Softcover - 9786204636498","offer_id":40026787807325,"sku":"9786204636498","price":24.8,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0940\/0622\/files\/6cd14905-f43c-42eb-9433-870f0a500b0a.png?v=1758089211","url":"https:\/\/shop.autorenwelt.de\/products\/immunogematologicheskij-i-biohimicheskij-profil-pacientow-von-oumu-daxe-konate","provider":"Autorenwelt Shop","version":"1.0","type":"link"}